Taiwan health authorities found excessive levels of the carcinogen benzo[a]pyrene in eight batches of camellia oil [1].
The discovery poses a significant public health risk because the contaminant is a known carcinogen. The Taiwan Food and Drug Administration said it is investigating how the chemical entered the production chain to prevent further exposure to consumers [1].
Officials traced all eight contaminated batches to a single oil refining plant located in Chiayi [1]. The contamination was reported in 2024, leading to an immediate response from regulatory bodies [1].
As a result of the findings, the refining plant in Chiayi has suspended operations [2]. This suspension allows health authorities to conduct a thorough inspection of the facility and its processing methods, a necessary step to identify the exact source of the benzo[a]pyrene (BaP) [1].
Benzo[a]pyrene is a polycyclic aromatic hydrocarbon that often occurs as a byproduct of incomplete combustion. The presence of this substance in food-grade oil indicates a failure in the refining process or contamination from external environmental sources [1].
Health authorities continue to monitor the distribution of the affected batches. The investigation remains focused on whether the contamination was a systemic failure at the Chiayi plant or an isolated incident affecting specific production runs [1], [2].
“Eight batches of camellia oil were found to contain excessive levels of the carcinogen benzo[a]pyrene.”
The suspension of the Chiayi plant highlights the critical role of food safety monitoring in the specialty oil market. Because camellia oil is often marketed as a health-conscious alternative, the presence of a known carcinogen like benzo[a]pyrene could undermine consumer trust in regional agricultural exports and necessitate stricter oversight of refining temperatures and filtration processes across Taiwan.
